ATXI (Avenue Therapeutics) OCF Margin %: 0.00% (As of Mar. 2026)

What is Avenue Therapeutics OCF Margin %?

Avenue Therapeutics ATXI -8.35% 31 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ATXI with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Avenue Therapeutics ranks worse than 51.09% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Avenue Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-0.44 Mil. Avenue Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Avenue Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Avenue Therapeutics's current OCF Yield % is -117.55%.

The historical rank and industry rank for Avenue Therapeutics's OCF Margin % or its related term are showing as below:

ATXI' s OCF Margin % Range Over the Past 10 Years
Min: -130.56 Med: -130.56 Max: -130.56
Current: -77.28

During the past 11 years, the highest OCF Margin % of Avenue Therapeutics was -130.56%. The lowest was -130.56%. And the median was -130.56%.

ATXI's OCF Margin % is ranked worse than
51.09% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs ATXI: -77.28

Avenue Therapeutics OCF Margin % Related Terms

Avenue Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Avenue Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avenue Therapeutics OCF Margin % Chart

Avenue Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

0.00

-130.56

Avenue Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															0.00	-12.54	0.00	0.00	0.00

ATXI vs PTIX, EVFM, AGTX: OCF Margin % Comparison

For the Biotechnology subindustry, Avenue Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avenue Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avenue Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Avenue Therapeutics's OCF Margin % falls into.

Save Embed

31GF Score

Avenue Therapeutics Inc ATXI

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Avenue Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Avenue Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-1.833	/	1.404
	=	-130.56 %

Avenue Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.438	/	0
	=	%

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of 0.00% mean?

Avenue Therapeutics (ATXI) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avenue Therapeutics and its competitors. According to the industry distribution chart, Avenue Therapeutics ranks #490 out of 959 companies in the Biotechnology industry, placing it in the top 51.1%.

Is Avenue Therapeutics' OCF Margin % too high?

Avenue Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Avenue Therapeutics ranks #490 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Avenue Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.

How does Avenue Therapeutics' OCF Margin % compare to PTIX and EVFM?

According to the Biotechnology industry distribution chart, Avenue Therapeutics ranks #490 out of 959 companies for OCF Margin %. This places Avenue Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avenue Therapeutics and its competitors. Avenue Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Avenue Therapeutics stock overvalued right now?

Avenue Therapeutics (ATXI) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Avenue Therapeutics' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Avenue Therapeutics (ATXI), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avenue Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies PTIX EVFM AGTX ABPO CERO EMMA LYRA ISCO ONCO VRAX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL, USA, 33154

Website https://www.avenuetx.com

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It is focused on advancing impactful therapies with the potential to overcome limitations of existing treatment options and ultimately transform patient outcomes. Current product candidates include ATX-04, a selective beta adrenergic agonist for Pompe disease, intravenous tramadol (IV tramadol), a Schedule IV opioid for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders. The company operates in one reportable segment, the development and commercialization of therapies for the treatment of neurologic diseases.

31GF Score

Get the complete analysis for ATXI

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28

Price

View ATXI Analysis

See OCF Margin % data for all stocks →